InflaRx vilobelimab fails to show statistical significance in severe COVID patients in trial
31 March 2022 - 11:19PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Apr 2024 to May 2024
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From May 2023 to May 2024